Prenetics Global Limited - Ordinary Shares - Class A

-0.02 (-0.30%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)82.10M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.7 Million
Adjusted EPS-$0.93
See more estimates
10-Day MA$6.21
50-Day MA$5.90
200-Day MA$5.20
See more pivots

Prenetics Global Limited - Ordinary Shares - Class A Stock, NASDAQ:PRE

Unit 703-706, K11 Atelier Kings Rd, 728 Kings Road, Hong Kong, George Town KY1-1106
Hong Kong
Phone: +852.2210.9588
Number of Employees: 324


Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the early detection, prevention, and treatment of cancer. It operates through the Prevention and Diagnostics segments. The firm offers products and services under the brands of CircleDNA, Insighta, and ACT Genomics. Its prevention arm, CircleDNA, uses whole exome sequencing to offer comprehensive consumer DNA test. The Insighta, a joint venture with scientist Prof. Dennis Lo, develops multi-cancer early detection technologies. Lastly, ACT Genomics treatment unit, an Asia-based company that achieved FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.